Biocept, Inc. (BIOCQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 25.85 Million | 61.24 Million | 27.46 Million | 5.52 Million |
| Cost of Revenue | 28.44 Million | 37.76 Million | 21.33 Million | 10.97 Million |
| Gross Profit | -2.58 Million | 23.48 Million | 6.12 Million | -5.44 Million |
| Operating Expenses | 29.4 Million | 25.89 Million | 21.59 Million | 17.6 Million |
| Selling, General and Administrative Expenses | 23.24 Million | 20.93 Million | 16.37 Million | 12.91 Million |
| Research and Development Expenses | 6.16 Million | 4.96 Million | 5.22 Million | 4.69 Million |
| Other Expenses | - | - | - | -1.83 Million |
| Cost and Expenses | 57.84 Million | 63.65 Million | 42.93 Million | 28.58 Million |
| Operating Income | -31.98 Million | -2.4 Million | -15.46 Million | -23.05 Million |
| Interest Expense | 316 Thousand | 290 Thousand | 236 Thousand | 249.98 Thousand |
| Income Tax Expense | -125 Thousand | 125 Thousand | 236 Thousand | 249.98 Thousand |
| Earnings before Tax | -32.21 Million | -2.69 Million | -17.8 Million | -25.13 Million |
| Net Income | -32.08 Million | -2.82 Million | -17.8 Million | -25.13 Million |
| Earnings Per Share Basic | -56.78 | -5.73 | -45.10 | -365.01 |
| Earnings Per Share Diluted | -56.78 | -5.73 | -45.10 | -365.01 |
| Weighted Average Shares Outstanding | 565.12 Thousand | 492.52 Thousand | 394.84 Thousand | 68.86 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 565.12 Thousand | 492.52 Thousand | 394.84 Thousand | 68.86 Thousand |
| Gross Margin | -0.10 | 0.38 | 0.22 | -0.99 |
| EBIT Margin | -1.17 | -0.01 | -0.53 | -4.03 |
| Profit Margin | -1.24 | -0.05 | -0.65 | -4.55 |
| EBITDA | -30.24 Million | -879 Thousand | -16.56 Million | -24.11 Million |
| Earnings Before Tax Margin | -1.24 | -0.04 | -0.56 | -4.17 |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2021 FY |
|---|---|---|---|---|---|---|
| Revenue | 589 Thousand | 673 Thousand | -10.28 Million | 25.85 Million | 1 Million | 61.24 Million |
| Cost of Revenue | 2.55 Million | 3.02 Million | 4.3 Million | 28.44 Million | 5.77 Million | 37.76 Million |
| Gross Profit | -1.96 Million | -2.35 Million | -14.59 Million | -2.58 Million | -4.76 Million | 23.48 Million |
| Operating Expenses | 4.15 Million | 4.74 Million | 4.01 Million | 29.4 Million | 5.38 Million | 25.89 Million |
| Selling, General and Administrative Expenses | 3.74 Million | 3.7 Million | 2.79 Million | - | 4.02 Million | - |
| Research and Development Expenses | 409 Thousand | 1.04 Million | 1.21 Million | - | 1.36 Million | - |
| Other Expenses | 91 Thousand | - | 3000.00 | 87 Thousand | - | - |
| Cost and Expenses | 6.7 Million | 7.77 Million | 8.31 Million | 57.84 Million | 11.16 Million | 63.65 Million |
| Operating Income | -6.11 Million | -7.09 Million | -18.6 Million | -31.98 Million | -10.15 Million | -2.4 Million |
| Interest Expense | 50 Thousand | 46 Thousand | 47 Thousand | 316 Thousand | 52 Thousand | 290 Thousand |
| Income Tax Expense | 141 Thousand | - | -125 Thousand | -125 Thousand | - | 125 Thousand |
| Earnings before Tax | -3.63 Million | -7.14 Million | -18.64 Million | -32.21 Million | -10.12 Million | -2.69 Million |
| Net Income | -3.63 Million | -7.14 Million | -18.52 Million | -32.08 Million | -10.12 Million | -2.82 Million |
| Earnings Per Share Basic | -3.50 | -12.16 | - | - | -17.87 | - |
| Earnings Per Share Diluted | -3.50 | -12.16 | - | - | -17.87 | - |
| Weighted Average Shares Outstanding | 1.03 Million | 587.35 Thousand | - | 565.12 Thousand | 566.6 Thousand | 492.52 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.03 Million | 587.35 Thousand | - | 565.12 Thousand | 566.6 Thousand | 492.52 Thousand |
| Gross Margin | -3.33 | -3.50 | 1.42 | -0.10 | -4.74 | 0.38 |
| EBIT Margin | -9.60 | -9.63 | 1.77 | - | -9.55 | - |
| Profit Margin | -6.16 | -10.62 | 1.80 | -1.24 | -10.05 | -0.05 |
| EBITDA | -5.65 Million | -6.48 Million | -18.16 Million | - | -9.61 Million | - |
| Earnings Before Tax Margin | -10.38 | -10.55 | 1.81 | -1.24 | -10.09 | -0.04 |
ASND
002199
VIZC
AYA
NER
SPNS